Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
Antimicrobial prescribing (39)
COVID-19 (12)
Type
Type
Guidance (1861)
NICE advice (323)
Quality standard (198)
Guidance programme
Guidance programme
Antimicrobial prescribing guidelines (20)
Cancer service guidelines (8)
Clinical guidelines (223)
COVID-19 rapid guidelines (3)
Diagnostics guidance (47)
Health technology evaluations (18)
Highly specialised technologies guidance (28)
Interventional procedures guidance (601)
Medical technologies guidance (67)
Medicines practice guidelines (5)
NICE guidelines (339)
Public health guidelines (61)
Safe staffing guidelines (2)
Social care guidelines (71)
Technology appraisal guidance (761)
Advice programme
Advice programme
Evidence summaries (68)
Medtech innovation briefings (255)
Apply filters
Showing 201 to 210 of 2382
Sort by
Date
Title
Apply sorting
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Avelumab with axitinib for untreated advanced renal cell carcinoma
TA645
2 September 2020
2 September 2020
Axicabtagene ciloleucel for treating diffuse large B-cell lymphoma and primary mediastinal large B-cell lymphoma after 2 or more systemic therapies
TA872
28 February 2023
28 February 2023
Axicabtagene ciloleucel for treating relapsed or refractory diffuse large B-cell lymphoma after first-line chemoimmunotherapy
TA895
7 June 2023
7 June 2023
Axicabtagene ciloleucel for treating relapsed or refractory follicular lymphoma
TA894
7 June 2023
7 June 2023
Axitinib for treating advanced renal cell carcinoma after failure of prior systemic treatment
TA333
25 February 2015
25 February 2015
Axonics sacral neuromodulation system for faecal incontinence
MIB259
4 May 2021
4 May 2021
Axonics sacral neuromodulation system for treating refractory overactive bladder
MTG50
3 September 2020
3 September 2020
Axumin for functional imaging of prostate cancer recurrence
MIB172
8 February 2019
8 February 2019
Axxent electronic brachytherapy system for early stage breast cancer
MIB76
24 August 2016
24 August 2016
Azacitidine for the treatment of myelodysplastic syndromes, chronic myelomonocytic leukaemia and acute myeloid leukaemia
TA218
23 March 2011
23 March 2011
Previous page
1
…
19
20
Current page
21
22
23
…
239
Page
21
of
239
Next page
Results per page
10
25
50
All
Back to top